Literature DB >> 26843407

Enterovirus 68 Infection--Association with Asthma.

Ronald B Moss1.   

Abstract

A previously sporadic virus called enterovirus 68 (EV-D68) appears to have been associated with asthma-like illness with a predisposition for asthmatics after an outbreak that occurred in North America in 2014. Clinicians should be aware of the clinical associations with EV-D68 particularly its predilection with pre-existing asthma or asthma-like illness as well as the potential association with acute flaccid myelitis. Further elucidation and development of diagnostic and treatments modalities are warranted to better understand and limit the potential public health impact of future outbreaks of EV-D68 infection.
Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asthma; EV-D68; Enterovirus

Mesh:

Year:  2016        PMID: 26843407     DOI: 10.1016/j.jaip.2015.12.013

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  4 in total

1.  Enterovirus D68 infection induces IL-17-dependent neutrophilic airway inflammation and hyperresponsiveness.

Authors:  Charu Rajput; Mingyuan Han; J Kelley Bentley; Jing Lei; Tomoko Ishikawa; Qian Wu; Joanna L Hinde; Amy P Callear; Terri L Stillwell; William T Jackson; Emily T Martin; Marc B Hershenson
Journal:  JCI Insight       Date:  2018-08-23

Review 2.  Epidemiology of Infections and Development of Asthma.

Authors:  Jenny Resiliac; Mitchell H Grayson
Journal:  Immunol Allergy Clin North Am       Date:  2019-04-30       Impact factor: 3.479

3.  Comparison of tissue tropism and host response to enteric and respiratory enteroviruses.

Authors:  Ines Cordeiro Filipe; Han Kang Tee; Julien Prados; Isabelle Piuz; Samuel Constant; Song Huang; Caroline Tapparel
Journal:  PLoS Pathog       Date:  2022-07-05       Impact factor: 7.464

Review 4.  Animal Models of Enterovirus D68 Infection and Disease.

Authors:  Meghan S Vermillion; Justin Dearing; Yun Zhang; Danielle R Adney; Richard H Scheuermann; Andrew Pekosz; E Bart Tarbet
Journal:  J Virol       Date:  2022-07-19       Impact factor: 6.549

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.